Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Nuclear Medicine|December 14, 2025
PET-CT radiomics for immunotherapy responseAlessia Artesani, Michela Olivieri, Priscilla Guglielmo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2025
Insights into pet-based radiogenomics in oncology: an updated systematic reviewLuca Filippi, Luca Urso, Luigi Manco, et al.
Cancers|October 14, 2022
Oral Candida spp. Colonisation Is a Risk Factor for Severe Oral Mucositis in Patients Undergoing Radiotherapy for Head & Neck Cancer: Results from a Multidisciplinary Mono-Institutional Prospective Observational StudyCosimo Rupe, Gioele Gioco, Giovanni Almadori, et al.
Expert Review of Medical Devices|June 28, 2025
Liver metastases in breast cancer: [18F]FDG and radioembolization as strategies for diagnosis and treatmentPriscilla Guglielmo, Michela Olivieri, Luca Filippi, et al.
Clinical and Translational Radiation Oncology|February 20, 2020
Refinement & validation of rectal wall dose volume objectives for prostate hypofractionation in 20 fractionsGiuseppe Sanguineti, Adriana Faiella, Alessia Farneti, et al.
Cancers|May 4, 2026
Comparing Response Evaluation Methods for PRRT in Neuroendocrine Tumors: Insights from an Exploratory StudyPriscilla Guglielmo, Carlo Carnaghi, Alexia Francesca Bertuzzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
External validation of an 18F-FDG-PET radiomic model predicting survival after radiotherapy for oropharyngeal cancerMartina Mori, Chiara Deantoni, Michela Olivieri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2022
A predictive nomogram for trismus after radiotherapy for head and neck cancerMariangela Massaccesi, Nicola Dinapoli, Valentina Fuga, et al.
La Radiologia Medica|December 20, 2024
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CTEttore di Gaeta, Michela Olivieri, Annarita Savi, et al.
Theranostics|June 5, 2026
First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493)Alessandro Larcher, Fabrizia Gelardi, Lidija Antunovic, et al.
Pageof 2